The increasing prevalence of diabetes worldwide has led to a rise in diabetic wounds, such as diabetic foot ulcers, which are challenging to treat and can result in amputation.
Formycon AG (von First Berlin Equity Research GmbH) – Biotech Investments
Original-Research: Formycon AG – from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Formycon AG Company Name: Formycon AG ISIN: